Global health is facing a tipping point. Scientific advancements have changed how we respond to epidemics like HIV/AIDS, tuberculosis, and malaria – and the pipeline of breakthrough innovations has never been stronger. But funding is down and priorities are shifting. Will the science come to scale so these diseases can finally be ended? Or will they surge instead?
On The Threshold, reporters from around the world cover this unfolding crisis from all sides—talking to scientists, politicians, civil society leaders, pharmaceutical executives, and others. The Threshold is a seven-part Foreign Policy podcast hosted by acclaimed broadcast journalist Henry Bonsu and made possible through funding in part from the Gates Foundation.
All content for The Threshold is the property of Foreign Policy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Global health is facing a tipping point. Scientific advancements have changed how we respond to epidemics like HIV/AIDS, tuberculosis, and malaria – and the pipeline of breakthrough innovations has never been stronger. But funding is down and priorities are shifting. Will the science come to scale so these diseases can finally be ended? Or will they surge instead?
On The Threshold, reporters from around the world cover this unfolding crisis from all sides—talking to scientists, politicians, civil society leaders, pharmaceutical executives, and others. The Threshold is a seven-part Foreign Policy podcast hosted by acclaimed broadcast journalist Henry Bonsu and made possible through funding in part from the Gates Foundation.
Tuberculosis claimed more than 1.25 million lives in 2023, overtaking COVID as the world’s deadliest infectious disease. For the last century, there has been a vaccine protecting children from TB. Now, there is hope for a new solution: a potential vaccine for adolescents and adults.
On this episode, reporter Elna Schütz visits an M72 TB vaccine trial site in Worcester, South Africa, one of the world’s TB epicenters. First, Elna speaks with participants about their experiences in the M72 trial and with TB more generally. She also interviews South Africa Tuberculosis Vaccine Initiative (SATVI) Director Mark Hatherill and Angelique Luabeya Kany-Kany, SATVI’s chief research officer. SATVI runs part of the M72 trial in Worcester.
Then, journalist Chhavi Sachdev interviews Soumya Swaminathan, principal advisor on tuberculosis for the health ministry of India and former WHO chief scientist, about what is needed to end TB as an epidemic. Dr. Swaminathan is also the head of the MS Swaminathan Research Foundation, a nonprofit advancing sustainable rural development and climate resilience.
The Threshold is made possible in part through funding from the Gates Foundation.
Guests and organizations:
Dr. Soumya Swaminathan, former WHO chief scientist and current principal advisor on TB for the health ministry of India.
Prof. Mark Hatherill, University of Cape Town and Director of SATVI, the South Africa Tuberculosis Vaccine Initiative.
Prof. Angelique Luabeya Kany-Kany, University of Cape Town and Chief Research Officer of SATVI, the South Africa Tuberculosis Vaccine Initiative.
The Threshold
Global health is facing a tipping point. Scientific advancements have changed how we respond to epidemics like HIV/AIDS, tuberculosis, and malaria – and the pipeline of breakthrough innovations has never been stronger. But funding is down and priorities are shifting. Will the science come to scale so these diseases can finally be ended? Or will they surge instead?
On The Threshold, reporters from around the world cover this unfolding crisis from all sides—talking to scientists, politicians, civil society leaders, pharmaceutical executives, and others. The Threshold is a seven-part Foreign Policy podcast hosted by acclaimed broadcast journalist Henry Bonsu and made possible through funding in part from the Gates Foundation.
